122 related articles for article (PubMed ID: 38614528)
21. Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.
Cuccarini V; Erbetta A; Farinotti M; Cuppini L; Ghielmetti F; Pollo B; Di Meco F; Grisoli M; Filippini G; Finocchiaro G; Bruzzone MG; Eoli M
J Neurooncol; 2016 Jan; 126(2):279-88. PubMed ID: 26468137
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
23. Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.
Sanz-Requena R; Revert-Ventura AJ; García-Martí G; Salamé-Gamarra F; Pérez-Girbés A; Mollá-Olmos E; Martí-Bonmatí L
Eur Radiol; 2017 Aug; 27(8):3392-3400. PubMed ID: 27999986
[TBL] [Abstract][Full Text] [Related]
24. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
[TBL] [Abstract][Full Text] [Related]
26. The imaging features and prognosis of gliomas involving the subventricular zone: An MRI study.
Zhao K; Liu R; Li Z; Liu M; Zhao Y; Xue Z; Wu W; Sun G; Xu B
Clin Neurol Neurosurg; 2022 Nov; 222():107465. PubMed ID: 36201899
[TBL] [Abstract][Full Text] [Related]
27. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
[TBL] [Abstract][Full Text] [Related]
28. The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
Fraioli F; Shankar A; Hyare H; Ferrazzoli V; Militano V; Samandouras G; Mankad K; Solda F; Zaccagna F; Mehdi E; Lyasheva M; Bomanji J; Novruzov F
Nucl Med Commun; 2020 Jun; 41(6):517-525. PubMed ID: 32282634
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
[TBL] [Abstract][Full Text] [Related]
30. Comparison between CT and MR in perfusion imaging assessment of high-grade gliomas.
De Simone M; Muccio CF; Pagnotta SM; Esposito G; Cianfoni A
Radiol Med; 2013 Feb; 118(1):140-51. PubMed ID: 22430675
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.
Ding B; Ling HW; Chen KM; Jiang H; Zhu YB
Neuroradiology; 2006 Oct; 48(10):773-81. PubMed ID: 16937146
[TBL] [Abstract][Full Text] [Related]
32. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Shishido F; Uemura K
Cancer; 1994 May; 73(9):2386-94. PubMed ID: 8168042
[TBL] [Abstract][Full Text] [Related]
33. Advanced and amplified BOLD fluctuations in high-grade gliomas.
Gupta L; Gupta RK; Postma AA; Sahoo P; Gupta PK; Patir R; Ahlawat S; Saha I; Backes WH
J Magn Reson Imaging; 2018 Jun; 47(6):1616-1625. PubMed ID: 28963852
[TBL] [Abstract][Full Text] [Related]
34. Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.
Gaudino S; Benenati M; Martucci M; Botto A; Infante A; Marrazzo A; Ramaglia A; Marziali G; Guadalupi P; Colosimo C
Radiol Med; 2020 Apr; 125(4):416-422. PubMed ID: 31916104
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Brain Tumour Perfusion Using Early-Phase
Filss CP; Cramer J; Löher S; Lohmann P; Stoffels G; Stegmayr C; Kocher M; Heinzel A; Galldiks N; Wittsack HJ; Sabel M; Neumaier B; Scheins J; Shah NJ; Meyer PT; Mottaghy FM; Langen KJ
Mol Imaging Biol; 2024 Feb; 26(1):36-44. PubMed ID: 37848641
[TBL] [Abstract][Full Text] [Related]
36. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
Smitha KA; Gupta AK; Jayasree RS
Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
[TBL] [Abstract][Full Text] [Related]
37. Comparison of
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of three-dimensional arterial spin labeling and how it compares against that of contrast enhanced magnetic resonance imaging in preoperative grading of brain gliomas.
Wang K; Guo H; Tian X; Miao Y; Han P; Jin F
Environ Toxicol; 2023 Jul; 38(7):1723-1731. PubMed ID: 37040330
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
40. The Utility of Diffusion and Perfusion Magnetic Resonance Imaging in Target Delineation of High-Grade Gliomas.
Fei Q; Qian LX; Zhang YJ; Guo WJ; Bian XH; Yin L; Yan PW; Wang TT; Qian PD; Guo Z; He X
Biomed Res Int; 2020; 2020():8718097. PubMed ID: 32851090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
